Johnson & Johnson to Present at Morgan Stanley Global Healthcare Conference

Johnson & Johnson will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on September 10, 2025, with a Fireside Chat at 11:30 a.m. Eastern Time. The live audio webcast will be available on Johnson & Johnson's Investor Relations website, with an archived edition available later that day. The audio webcast replay will be available approximately 48 hours after the webcast.

Johnson & Johnson (NYSE: JNJ) has announced its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference, scheduled for Wednesday, September 10, 2025. The pharmaceutical giant will hold a Fireside Chat at 11:30 a.m. Eastern Time [1].

The event will be streamed live on Johnson & Johnson's Investor Relations website, www.investor.jnj.com, providing investors and financial professionals with the opportunity to engage with the company's management team in real-time. An archived version of the session will be available later that day, and a replay will be accessible approximately 48 hours after the webcast [1].

This annual conference is a significant platform for healthcare companies to discuss industry trends, innovations, and strategic initiatives. Johnson & Johnson's participation underscores its commitment to transparency and investor relations. The company's management is expected to provide insights into its recent developments, future plans, and responses to market challenges.

Investors and financial professionals are encouraged to tune in to the live webcast and access the archived content for a comprehensive understanding of Johnson & Johnson's current and future prospects.

References:
[1] https://www.businesswire.com/news/home/20250730478546/en/